- Home
- FBIOP vs LTRY Comparison
FBIOP vs LTRY Comparison
Compare FBIOP & LTRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FBIOP
- LTRY
- Stock Information
- Founded
- FBIOP N/A
- LTRY 2015
- Country
- FBIOP United States
- LTRY United States
- Employees
- FBIOP 186
- LTRY N/A
- Industry
- FBIOP Biotechnology: Pharmaceutical Preparations
- LTRY Computer Software: Prepackaged Software
- Sector
- FBIOP Health Care
- LTRY Technology
- Exchange
- FBIOP Nasdaq
- LTRY Nasdaq
- Market Cap
- FBIOP N/A
- LTRY N/A
- IPO Year
- FBIOP N/A
- LTRY N/A
- Fundamental
- Price
- FBIOP $5.08
- LTRY $0.31
- Analyst Decision
- FBIOP
- LTRY
- Analyst Count
- FBIOP 0
- LTRY 0
- Target Price
- FBIOP N/A
- LTRY N/A
- AVG Volume (30 Days)
- FBIOP N/A
- LTRY 322.1K
- Earning Date
- FBIOP N/A
- LTRY 11-29-2024
- Dividend Yield
- FBIOP N/A
- LTRY N/A
- EPS Growth
- FBIOP N/A
- LTRY N/A
- EPS
- FBIOP N/A
- LTRY N/A
- Revenue
- FBIOP N/A
- LTRY $6,228,218.00
- Revenue This Year
- FBIOP N/A
- LTRY N/A
- Revenue Next Year
- FBIOP N/A
- LTRY N/A
- P/E Ratio
- FBIOP N/A
- LTRY N/A
- Revenue Growth
- FBIOP N/A
- LTRY 145.32
- 52 Week Low
- FBIOP N/A
- LTRY $0.22
- 52 Week High
- FBIOP N/A
- LTRY $7.01
- Technical
- Relative Strength Index (RSI)
- FBIOP 49.96
- LTRY 38.96
- Support Level
- FBIOP $5.01
- LTRY $0.30
- Resistance Level
- FBIOP $5.86
- LTRY $0.35
- Average True Range (ATR)
- FBIOP 0.51
- LTRY 0.05
- MACD
- FBIOP -0.03
- LTRY 0.01
- Stochastic Oscillator
- FBIOP 28.99
- LTRY 51.24
About FBIOP Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology, therapeutics sectors.